Ophthalmology

Top Story

Xiidra first FDA-approved drug for signs and symptoms of dry eye disease

July 28, 2016

The FDA approved Xiidra for the treatment of signs and symptoms of dry eye disease in adult patients on July 11.

Manufactured by Shire, Xiidra (lifitegrast ophthalmic solution 5%) is the first prescription eye drop medication in a new class of drugs, a lymphocyte function-associated antigen 1 antagonist, to be approved by the FDA for dry eye disease, according to an FDA press release. The drug’s safety and efficacy were assessed in more than 2,500 patients in four separate, randomized controlled studies. The results of the studies found that patients treated with Xiidra demonstrated improvement in their signs and symptoms of dry eye compared with patients treated with placebo.

FDA News

CenterVue launches training module to aid low vision patients

July 28, 2016
CenterVue announced 510(k) clearance for its fixation training for the MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio…

pSivida’s Medidur maintains primary endpoint results at 12 months

July 28, 2016
Medidur statistically significantly prevented recurrence of posterior uveitis through 12 months, pSivida announced in a press release. Prevention of recurrence of…
Meeting News Coverage

Researchers find association between retinal nerve fiber layer thinning, poor cognition

July 28, 2016
Patients who scored abnormally on any one cognition test had a thinner retinal nerve fiber layer thickness compared with patients who did not score abnormally, according…
Meeting News CoverageVideo

VIDEO: Speaker talks about persistent iritis after cataract surgery

July 28, 2016
At Kiawah Eye, Kristin Neatrour, MD, presents results of a study evaluating patients with postoperative iritis after cataract surgery to determine the prevalence and…
More News Headlines »
Clinical Science

Optical Coherence Tomography and Multifocal Electroretinography in Diabetic Macular Edema: A Neurovascular Relation With Vision

Ophthalmic Surgery, Lasers and Imaging Retina, July 2016, Volume 47 Issue 7
To evaluate retinal neuropathy in patients with diabetic macular edema (DME) with multifocal electroretinograph…
More »
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: Speaker talks about persistent iritis after cataract surgery

July 28, 2016
More »